Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Handling Overages in Batch Preparation – V 2.0

Posted on By

Elixir Department: SOP for Handling Overages in Batch Preparation – V 2.0

Standard Operating Procedure for Handling Overages in Batch Preparation of Elixirs

Department Elixir Department
SOP No. SOP/ELX/071/2025
Supersedes SOP/ELX/071/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a procedure for the identification, documentation, and appropriate handling of overages observed during batch preparation of elixirs in order to ensure regulatory compliance and product quality.

2. Scope

This SOP applies to all batch manufacturing operations in the Elixir Department where raw material or product overages may occur during dispensing, mixing, or volume adjustments.

3. Responsibilities

  • Production Operator:
    • Report any overages immediately to the supervisor and record in the BMR.
    • Ensure all excess material is properly labeled and segregated.
  • Production Supervisor:
    • Verify the overage quantity and initiate further action based on type of overage.
    • Ensure reconciliation of actual vs theoretical yield is documented.
  • QA Officer:
    • Review overage handling records and provide clearance or disposition instructions.
See also  Elixir Department: SOP for Calibration of Temperature Probes - V 2.0

4. Accountability

The Production Head is accountable for ensuring all overages are handled as per this SOP and compliant with cGMP documentation practices.

5. Procedure

5.1 Types of Overages

  1. Raw Material Overages: More than required quantity of materials weighed or transferred into manufacturing vessel.
  2. Final Product Overages: Elixir volume exceeds theoretical volume post-processing due to measurement variation or adjustment errors.

5.2 Raw Material Overages

  1. If overage is within ±0.5% of theoretical quantity:
    • Acceptable; document actual dispensed quantity in the BMR.
  2. If overage exceeds ±0.5%:
    • Report immediately to the supervisor and QA.
    • Initiate deviation report and assess impact on batch quality.

5.3 Final Product Overages

  1. Measure the final batch volume using calibrated dip stick or level sensor.
  2. If excess volume is within 2%:
    • Document and proceed for filling after QA review.
  3. If volume exceeds 2%:
    • Sample and test the overage portion for assay, pH, microbial quality.
    • Segregate excess in a separate labeled container as “Overage – Awaiting QA Disposition.”
See also  Elixir Department: SOP for Compressed Air System in Mixing Units - V 2.0

5.4 Labeling and Storage

  1. All overages must be labeled with:
    • Batch No.
    • Date
    • “Overage – Hold for QA Decision”
    • Container No. and Volume
  2. Store in designated area with restricted access until disposition.

5.5 Disposition of Overages

  1. Overages may be:
    • Used for filling, if approved by QA after testing.
    • Reprocessed (if validated) or destroyed as per waste SOP.
  2. Update the BMR and complete the Overage Handling Log (Annexure-1).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • cGMP: Current Good Manufacturing Practice

7. Documents

  1. Overage Handling Log (Annexure-1)
  2. Overage Label Template (Annexure-2)
  3. Deviation Report (if applicable)
See also  Elixir Department: SOP for Heavy Metal Testing - V 2.0

8. References

  • 21 CFR Part 211.103 – Calculation of Yield
  • WHO GMP Guidelines for Documentation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Overage Handling Log

Date Batch No. Type of Overage Quantity Disposition QA Reviewed By
11/04/2025 ELX-1014 Final Product 4 Litres Approved for Filling Sunita Reddy

Annexure-2: Overage Label Template

Label Field Example Entry
Material Paracetamol Elixir
Batch No. ELX-1014
Volume 4 L
Date 11/04/2025
Status Overage – Hold for QA

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added Raw and Final Product Overage Handling Criteria Process Clarification QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: API Manufacturing: SOP for Sample Disposal After Analysis – V 2.0
Next Post: Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version